Chronic obstructive pulmonary disease is one of the world’s leading causes of death - more than 300 million live with the ...

has been studied in severe asthmatics and in COPD patients with a history of asthma, showing an additional bronchodilator effect on top of the current asthma treatment. The first large study on ...

The Spanish COPD guidelines recommend treatment of the mixed COPD–asthma phenotype with ICS and a long-acting bronchodilator (LABD) as a first option to improve lung function, respiratory ...

Poor treatment of asthma and COPD puts a huge burden on the NHS. For example, £1 billion is spent on asthma treatment in the UK each year and represents 60,000 to 65,000 hospital admissions.

The chronic obstructive pulmonary disease (COPD) market in the seven major markets (7MM: US, France, Germany, Italy, Spain, ...

Inhalers used to treat symptoms of respiratory disease can be potent sources of greenhouse gases. Drugmakers are planning to ...

Steroid tablets are associated with significant adverse side effects. Short-term use risks sleep disturbance, reflux, ...

Two posters presented at the CHEST 2024 annual meeting showed that mepolizumab significantly reduces exacerbations in ...

Patients with asthma and COPD routinely switch from pressurized metered-dose inhalers to dry powder inhalers and vice versa.

Many similarities exist between COPD and asthma, including symptoms including breathing difficulties and restricted airways. COPD is progressive and persistent, though. Allergens can aggravate asthma ...

Researchers assigned half of trial participants to usual care (their primary care provider or a walk-in-clinic) and the other half to lung specialists and asthma/COPD educators (specially trained ...

The Asthma Society of Ireland has warned that over-use of steroid medication may cause more harm than good. A study has shown ...